A groundbreaking blood test has been developed by scientists from the Walter and Eliza Hall Institute of Medical Research, in collaboration with Novoviah Pharmaceuticals. The new test can detect gluten-specific immune cells, or T cells, even when they’re not actively fighting inflammation, simplifying the diagnosis of celiac disease.
The current method of diagnosing celiac disease involves exposing patients to gluten for several weeks, followed by a series of tests. This new blood test eliminates the need for this exposure therapy, making it a significant improvement over existing diagnostic methods.
According to experts, one in 141 Americans has celiac disease, with a higher prevalence among people of European background or those with other conditions such as type 1 diabetes or irritable bowel syndrome. The test boasts a high sensitivity and specificity rate, accurate even in individuals with asymptomatic celiac disease.
Source: https://newatlas.com/diet-nutrition/celiac-blood-test